[1 J. Bruix and M. Sherman, Management of hepatocellular carcinoma: An update, Hepatology53 (2011) 1020–1022; https://doi.org/10.1002/hep.2419910.1002/hep.24199308499121374666]Search in Google Scholar
[2. U. Asghar and T. Meyer, Are there opportunities for chemotherapy in the treatment of hepatocellular cancer? J. Hepatol.56 (2012) 686–695; https://doi.org/10.1016/j.jhep.2011.07.03110.1016/j.jhep.2011.07.03121971559]Search in Google Scholar
[3. S. R. Chen, H.C. Qiu, Y. Hu, Y. Wang and Y. T. Wang, Herbal medicine offered as an initiative therapeutic option for the management of hepatocellular carcinoma, Phytother. Res.30 (2016) 863–877; https://doi.org/10.1002/ptr.559410.1002/ptr.559426879574]Search in Google Scholar
[4. B. Kocaadam and N. Sanlier, Curcumin, an active component of turmeric (Curcuma longa), and its effects on health, Crit. Rev. Food Sci. Nutr.57 (2017) 2889–2895; https://doi.org/10.1080/10408398.2015.107719510.1080/10408398.2015.107719526528921]Search in Google Scholar
[5. H. Mahammedi, E. Planchat, M. Pouget, X. Durando, H. Cure, L. Guy, I. Van-Praagh, L. Savareux, M. Atger, M. Bayet-Robert, E. Gadea, C. Abrial, E. Thivat, P. Chollet and J. C. Eymard, The new combination docetaxel, prednisone and curcumin in patients with castration-resistant prostate cancer: A Pilot Phase II Study, Oncology90 (2016) 69–78; https://doi.org/10.1159/00044114810.1159/00044114826771576]Search in Google Scholar
[6. W. Z. Wang, L. Li, M. Y. Liu, X. B. Jin, J. W. Mao, Q. H. Pu, M. J. Meng, X. G. Chen and J. Y. Zhu, Curcumin induces FasL-related apoptosis through p38 activation in human hepatocellular carcinoma Huh7 cells, Life Sci.92 (2013) 352–358; https://doi.org/doi:10.1016/j.lfs.2013.01.01310.1016/j.lfs.2013.01.01323352975]Search in Google Scholar
[7. M. I. James, C. Iwuji, G. Irving, A. Karmokar, J. A. Higgins, N. Griffin-Teal, A. Thomas, P. Greaves, H. Cai, S. R. Patel, B. Morgan, A. Dennison, M. Metcalfe, G. Garcea, D. M. Lloyd, D. P. Berry, W. P. Steward, L. M. Howells and K. Brown, Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy, Cancer Lett.364 (2015) 135–141; https://doi.org/10.1016/j.canlet.2015.05.00510.1016/j.canlet.2015.05.005451014425979230]Search in Google Scholar
[8. R. A. Sharma, S. A. Euden, S. L. Platton, D. N. Cooke, A. Shafayat, H. R. Hewitt, T. H. Marczylo, B. Morgan, D. Hemingway, S. M. Plummer, M. Pirmohamed, A. J. Gescher and W. P. Steward, Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance, Clin. Cancer Res.10 (2004) 6847–6854; https://doi.org/10.1158/1078-0432.CCR-04-074410.1158/1078-0432.CCR-04-074415501961]Search in Google Scholar
[9. D. Ghosh, S. T. Choudhury, S. Ghosh, A. K. Mandal, S. Sarkar, A. Ghosh, K. D. Saha and N. Das, Nanocapsulated curcumin: oral chemopreventive formulation against diethylnitrosamine induced hepatocellular carcinoma in rat, Chem. Biol. Int.195 (2012) 206–214; https://doi.org/10.1016/j.cbi.2011.12.00410.1016/j.cbi.2011.12.00422197969]Search in Google Scholar
[10. F. Wang, J. Chen, W. Dai, Z. He, D. Zhai and W. Chen, Pharmacokinetic studies and anticancer activity of curcumin-loaded nanostructured lipid carriers, Acta Pharm.67 (2017) 597–605; https://doi.org/10.1515/acph-2017-002110.1515/acph-2017-002128858837]Search in Google Scholar
[11. F. Wang, Z. He, W. Dai, Q. Li, X. Liu, Z. Zhang, D. Zhai, J. Chen and W. Chen, The role of the vascular endothelial growth factor/vascular endothelial growth factor receptors axis mediated angiogenesis in curcumin-loaded nanostructured lipid carriers induced human HepG2 cells apoptosis, J. Cancer Res. Ther.11 (2015) 597–605; https://doi.org/10.4103/0973-1482.15908610.4103/0973-1482.159086]Search in Google Scholar
[12. S. Fulda, Targeting apoptosis for anticancer therapy, Semin. Cancer Biol.31 (2015) 84–88. https://doi.org/10.1016/j.semcancer.2014.05.00210.1016/j.semcancer.2014.05.002]Search in Google Scholar
[13. F. C. Kischkel, D. A. Lawrence, A. Chuntharapai, P. Schow, K. J. Kim and A. Ashkenazi, Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5, Immunity12 (2000) 611–620; https://doi.org/10.1016/s1074-7613(00)80212-510.1016/S1074-7613(00)80212-5]Search in Google Scholar
[14. J. Chen, W. T. Dai, Z. M. He, L. Gao, X. Huang, J. M. Gong, H. Y. Xing and W. D. Chen, Fabrication and evaluation of curcumin-loaded nanoparticles based on solid lipid as a new type of colloidal drug delivery system, Indian J. Pharm. Sci.75 (2013) 178–184.]Search in Google Scholar
[15. J. Li and J. Yuan, Caspases in apoptosis and beyond, Oncogene27 (2008) 6194–6206. https://doi.org/10.1038/onc.2008.29710.1038/onc.2008.29718931687]Search in Google Scholar